| Year |
Citation |
Score |
| 2024 |
Williams J, Bonner J, Kibler K, Jacobs BL. Type I Interferon: Monkeypox/Mpox Viruses Achilles Heel? Advances in Experimental Medicine and Biology. 1451: 125-137. PMID 38801575 DOI: 10.1007/978-3-031-57165-7_8 |
0.316 |
|
| 2023 |
Watters CR, Barro O, Elliott NM, Zhou Y, Gabere M, Raupach E, Baker AT, Barrett MT, Buetow KH, Jacobs B, Seetharam M, Borad MJ, Nagalo BM. Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma. Molecular Therapy Oncolytics. 29: 4-14. PMID 36969560 DOI: 10.1016/j.omto.2023.02.009 |
0.33 |
|
| 2023 |
Szczerba M, Johnson B, Acciai F, Gogerty C, McCaughan M, Williams J, Kibler KV, Jacobs BL. Canonical cellular stress granules are required for arsenite-induced necroptosis mediated by Z-DNA-binding protein 1. Science Signaling. 16: eabq0837. PMID 36917643 DOI: 10.1126/scisignal.abq0837 |
0.44 |
|
| 2023 |
Rahman MM, Estifanos B, Glenn HL, Kibler K, Li Y, Jacobs B, McFadden G, Hogue BG. Nuclear export inhibitor Selinexor targeting XPO1 enhances coronavirus replication. Biorxiv : the Preprint Server For Biology. PMID 36824761 DOI: 10.1101/2023.02.09.527884 |
0.346 |
|
| 2022 |
Kibler KV, Szczerba M, Lake D, Roeder AJ, Rahman M, Hogue BG, Roy Wong LY, Perlman S, Li Y, Jacobs BL. Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y Strain of SARS-CoV-2. Vaccines. 10. PMID 35893821 DOI: 10.3390/vaccines10081172 |
0.311 |
|
| 2022 |
Szczerba M, Subramanian S, Trainor K, McCaughan M, Kibler KV, Jacobs BL. Small Hero with Great Powers: Vaccinia Virus E3 Protein and Evasion of the Type I IFN Response. Biomedicines. 10. PMID 35203445 DOI: 10.3390/biomedicines10020235 |
0.356 |
|
| 2021 |
Kibler KV, Szczerba M, Lake D, Roeder AJ, Rahman M, Hogue BG, Wong LR, Perlman S, Li Y, Jacobs BL. Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y strain of SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 34909775 DOI: 10.1101/2021.12.06.471483 |
0.311 |
|
| 2021 |
Águeda-Pinto A, Alves LQ, Neves F, McFadden G, Jacobs BL, Castro LFC, Rahman MM, Esteves PJ. Convergent Loss of the Necroptosis Pathway in Disparate Mammalian Lineages Shapes Viruses Countermeasures. Frontiers in Immunology. 12: 747737. PMID 34539677 DOI: 10.3389/fimmu.2021.747737 |
0.308 |
|
| 2021 |
Richard HB, Minder S, Sidhu A, Juba AN, Jancovich JK, Jacobs BL, Wellensiek BP. Optimization of translation enhancing element use to increase protein expression in a vaccinia virus system. The Journal of General Virology. 102. PMID 34382930 DOI: 10.1099/jgv.0.001624 |
0.361 |
|
| 2021 |
Koehler HS, Jacobs BL. Subversion of Programed Cell Death by Poxviruses. Current Topics in Microbiology and Immunology. PMID 33507400 DOI: 10.1007/82_2020_229 |
0.315 |
|
| 2020 |
Kannan L, Kumar A, Kumar A, Jacobs B, Langland J. Anti-herpes virus activity of the carnivorous botanical, Sarracenia purpurea. Scientific Reports. 10: 18953. PMID 33144625 DOI: 10.1038/s41598-020-76151-w |
0.416 |
|
| 2019 |
Giel-Moloney M, Esteban M, Oakes BH, Vaine M, Asbach B, Wagner R, Mize GJ, Spies AG, McElrath J, Perreau M, Roger T, Ives A, Calandra T, Weiss D, Perdiguero B, ... ... Jacobs B, et al. Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector. Scientific Reports. 9: 20005. PMID 31882800 DOI: 10.1038/S41598-019-56550-4 |
0.475 |
|
| 2019 |
Meador LR, Kessans SA, Kilbourne J, Kibler KV, Pantaleo G, Esteban M, Blattman JN, Jacobs BL, Mor TS. Corrigendum to "A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles" [Virology 507 (2017) 242-256]. Virology. PMID 31178060 DOI: 10.1016/J.Virol.2019.05.018 |
0.393 |
|
| 2018 |
Asbach B, Kibler KV, Köstler J, Perdiguero B, Yates NL, Stanfield-Oakley S, Tomaras GD, Kao SF, Foulds KE, Roederer M, Seaman MS, Montefiori DC, Parks R, Ferrari G, Forthal DN, ... ... Jacobs BL, et al. Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost. Journal of Virology. PMID 30429343 DOI: 10.1128/Jvi.01529-18 |
0.317 |
|
| 2018 |
Kibler KV, Asbach B, Perdiguero B, García-Arriaza J, Yates NL, Parks R, Stanfield-Oakley S, Ferrari G, Montefiori DC, Tomaras GD, Roederer M, Foulds KE, Forthal DN, Seaman MS, Self S, ... ... Jacobs BL, et al. Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC. Journal of Virology. PMID 30429340 DOI: 10.1128/Jvi.01513-18 |
0.386 |
|
| 2018 |
Langland J, Jacobs B, Wagner C, Ruiz G, Cahill TM. Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses. Antiviral Research. PMID 30393014 DOI: 10.1016/J.Antiviral.2018.10.021 |
0.397 |
|
| 2018 |
Saunders KO, Santra S, Parks R, Yates NL, Sutherland LL, Scearce RM, Balachandran H, Bradley T, Goodman D, Eaton A, Stanfield-Oakley SA, Tartaglia J, Phogat S, Pantaleo G, Esteban M, ... ... Jacobs B, et al. Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates. Journal of Virology. PMID 29437967 DOI: 10.1128/Jvi.02035-17 |
0.467 |
|
| 2018 |
Jankovich JK, Chapman D, Hansen DT, Robida MD, Loskutov A, Craciunescu F, Borovkov A, Kibler K, Goatley L, King K, Netherton CL, Taylor G, Jacobs B, Sykes K, Dixon LK. Immunisation of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins. Journal of Virology. PMID 29386289 DOI: 10.1128/Jvi.02219-17 |
0.502 |
|
| 2017 |
Koehler H, Cotsmire S, Langland J, Kibler KV, Kalman D, Upton JW, Mocarski ES, Jacobs BL. Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3. Proceedings of the National Academy of Sciences of the United States of America. 114: 11506-11511. PMID 29073079 DOI: 10.1073/Pnas.1700999114 |
0.358 |
|
| 2017 |
Huynh TP, Jancovich JK, Tripuraneni L, Heck MC, Langland JO, Jacobs BL. Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system. Virology. PMID 28919326 DOI: 10.1016/J.Virol.2017.08.012 |
0.731 |
|
| 2017 |
Meador LR, Kessans SA, Kilbourne J, Kibler KV, Pantaleo G, Roderiguez ME, Blattman JN, Jacobs BL, Mor TS. A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles. Virology. 507: 242-256. PMID 28458036 DOI: 10.1016/J.Virol.2017.04.008 |
0.405 |
|
| 2017 |
Zurawski G, Shen X, Zurawski S, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Klucar P, Wang Z, Foulds KE, Kao SF, Yu X, Sato A, Yates NL, ... ... Jacobs B, et al. Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses. Journal of Virology. PMID 28202751 DOI: 10.1128/Jvi.01596-16 |
0.403 |
|
| 2017 |
García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, ... ... Jacobs BL, et al. HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell immune functions in non-human primates. Journal of Virology. PMID 28179536 DOI: 10.1128/Jvi.02182-16 |
0.318 |
|
| 2016 |
Arndt WD, White SD, Johnson BP, Huynh T, Liao J, Harrington H, Cotsmire S, Kibler KV, Langland J, Jacobs BL. Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus. Virology. 497: 125-135. PMID 27467578 DOI: 10.1016/J.Virol.2016.07.016 |
0.811 |
|
| 2016 |
Denzler K, Moore J, Harrington H, Morrill K, Huynh T, Jacobs B, Waters R, Langland J. Characterization of the Physiological Response following In Vivo Administration of Astragalus membranaceus. Evidence-Based Complementary and Alternative Medicine : Ecam. 2016: 6861078. PMID 27190535 DOI: 10.1155/2016/6861078 |
0.62 |
|
| 2015 |
Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV, Huynh TP, Jacobs BL. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus. Journal of Virology. 89: 10489-99. PMID 26246580 DOI: 10.1128/Jvi.00304-15 |
0.807 |
|
| 2015 |
McAfee MS, Huynh TP, Johnson JL, Jacobs BL, Blattman JN. Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity. Virology. 484: 153-162. PMID 26099694 DOI: 10.1016/J.Virol.2015.05.021 |
0.702 |
|
| 2015 |
García-Arriaza J, Perdiguero B, Heeney J, Seaman M, Montefiori DC, Labranche C, Yates NL, Shen X, Tomaras GD, Ferrari G, Foulds KE, McDermott A, Kao SF, Roederer M, Hawkins N, ... ... Jacobs B, et al. Head-to-head comparison of poxvirus NYVAC and ALVAC vectors expressing identical HIV-1 clade C immunogens in prime/boost combination with Env protein in non-human primates. Journal of Virology. PMID 26041302 DOI: 10.1128/Jvi.01265-15 |
0.394 |
|
| 2015 |
Hulot SL, Korber B, Giorgi EE, Vandergrift N, Saunders KO, Balachandran H, Mach LV, Lifton MA, Pantaleo G, Tartaglia J, Phogat S, Jacobs B, Kibler K, Perdiguero B, Gomez CE, et al. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. Journal of Virology. 89: 6462-80. PMID 25855741 DOI: 10.1128/Jvi.00383-15 |
0.424 |
|
| 2015 |
Perdiguero B, Gómez CE, Cepeda V, Sánchez-Sampedro L, García-Arriaza J, Mejías-Pérez E, Jiménez V, Sánchez C, Sorzano CÓ, Oliveros JC, Delaloye J, Roger T, Calandra T, Asbach B, Wagner R, ... ... Jacobs BL, et al. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles. Journal of Virology. 89: 970-88. PMID 25355891 DOI: 10.1128/JVI.02469-14 |
0.356 |
|
| 2014 |
Tsen SW, Kingsley DH, Kibler K, Jacobs B, Sizemore S, Vaiana SM, Anderson J, Tsen KT, Achilefu S. Pathogen reduction in human plasma using an ultrashort pulsed laser. Plos One. 9: e111673. PMID 25372037 DOI: 10.1371/Journal.Pone.0111673 |
0.33 |
|
| 2013 |
Holechek SA, Denzler KL, Heck MC, Schriewer J, Buller RM, Legrand FA, Verardi PH, Jones LA, Yilma T, Jacobs BL. Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses. Plos One. 8: e77879. PMID 24147092 DOI: 10.1371/Journal.Pone.0077879 |
0.806 |
|
| 2013 |
Marsiglia FF, Jacobs BL, Nieri T, Smith SJ, Salamone D, Booth J. Effects of an undergraduate HIV/AIDS course on students' HIV risk. Journal of Hiv/Aids & Social Services. 12: 172-189. PMID 24058288 DOI: 10.1080/15381501.2013.790750 |
0.682 |
|
| 2012 |
Arndt W, Mitnik C, Denzler KL, White S, Waters R, Jacobs BL, Rochon Y, Olson VA, Damon IK, Langland JO. In vitro characterization of a nineteenth-century therapy for smallpox. Plos One. 7: e32610. PMID 22427855 DOI: 10.1371/Journal.Pone.0032610 |
0.725 |
|
| 2012 |
White SD, Jacobs BL. The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response. Journal of Virology. 86: 5895-904. PMID 22419806 DOI: 10.1128/JVI.06889-11 |
0.386 |
|
| 2012 |
Hulot S, Korber B, Pantaleo G, Tartaglia J, Jacobs B, Perdiguero B, Gomez C, Esteban M, Letvin N, Seaman M, Haynes B, Santra S. Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-P288 |
0.344 |
|
| 2011 |
Kibler KV, Gomez CE, Perdiguero B, Wong S, Huynh T, Holechek S, Arndt W, Jimenez V, Gonzalez-Sanz R, Denzler K, Haddad EK, Wagner R, Sékaly RP, Tartaglia J, Pantaleo G, ... Jacobs BL, et al. Improved NYVAC-based vaccine vectors. Plos One. 6: e25674. PMID 22096477 DOI: 10.1371/Journal.Pone.0025674 |
0.802 |
|
| 2011 |
Denzler KL, Babas T, Rippeon A, Huynh T, Fukushima N, Rhodes L, Silvera PM, Jacobs BL. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques. Vaccine. 29: 9684-90. PMID 22001879 DOI: 10.1016/J.Vaccine.2011.09.135 |
0.73 |
|
| 2011 |
Denzler KL, Schriewer J, Parker S, Werner C, Hartzler H, Hembrador E, Huynh T, Holechek S, Buller RM, Jacobs BL. The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus. Vaccine. 29: 9691-6. PMID 21983358 DOI: 10.1016/J.Vaccine.2011.09.108 |
0.81 |
|
| 2011 |
Denzler KL, Rice AD, MacNeill AL, Fukushima N, Lindsey SF, Wallace G, Burrage AM, Smith AJ, Manning BR, Swetnam DM, Gray SA, Moyer RW, Jacobs BL. The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus. Vaccine. 29: 7659-69. PMID 21840358 DOI: 10.1016/j.vaccine.2011.07.140 |
0.398 |
|
| 2011 |
White SD, Conwell K, Langland JO, Jacobs BL. Use of a negative selectable marker for rapid selection of recombinant vaccinia virus. Biotechniques. 50: 303-9. PMID 21548892 DOI: 10.2144/000113667 |
0.414 |
|
| 2011 |
Jancovich JK, Jacobs BL. Innate immune evasion mediated by the Ambystoma tigrinum virus eukaryotic translation initiation factor 2alpha homologue. Journal of Virology. 85: 5061-9. PMID 21389122 DOI: 10.1128/JVI.01488-10 |
0.455 |
|
| 2011 |
Quakkelaar ED, Redeker A, Haddad EK, Harari A, McCaughey SM, Duhen T, Filali-Mouhim A, Goulet JP, Loof NM, Ossendorp F, Perdiguero B, Heinen P, Gomez CE, Kibler KV, Koelle DM, ... ... Jacobs BL, et al. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. Plos One. 6: e16819. PMID 21347234 DOI: 10.1371/Journal.Pone.0016819 |
0.34 |
|
| 2010 |
Pantaleo G, Esteban M, Jacobs B, Tartaglia J. Poxvirus vector-based HIV vaccines. Current Opinion in Hiv and Aids. 5: 391-6. PMID 20978379 DOI: 10.1097/Coh.0B013E32833D1E87 |
0.382 |
|
| 2010 |
Tsen KT, Tsen SWD, Fu Q, Lindsay SM, Kibler K, Jacobs B, Wu TC, Li Z, Yan H, Cope S, Vaiana S, Kiang JG. Photonic approach to the selective inactivation of viruses with a near-infrared ultrashort pulsed laser Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7561. DOI: 10.1117/12.841316 |
0.422 |
|
| 2009 |
Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR. Vaccinia virus vaccines: past, present and future. Antiviral Research. 84: 1-13. PMID 19563829 DOI: 10.1016/J.Antiviral.2009.06.006 |
0.811 |
|
| 2009 |
Zhang P, Langland JO, Jacobs BL, Samuel CE. Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L. Journal of Virology. 83: 5718-25. PMID 19321614 DOI: 10.1128/JVI.00224-09 |
0.315 |
|
| 2009 |
Quakkelaar E, Redeker A, Loof N, Perdiguero B, Heinen P, Nieto J, Esteban M, Kibler K, Jacobs B, Pantaleo G, Melief C. P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro Retrovirology. 6: 305. DOI: 10.1186/1742-4690-6-S3-P305 |
0.504 |
|
| 2009 |
Jacobs B, Kibler K, Wong S, Huynh T, Holechek S, Denzler K, Arndt W, Parrington M, Tartaglia J, Pantaleo G. OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-O13 |
0.799 |
|
| 2008 |
Jentarra GM, Heck MC, Youn JW, Kibler K, Langland JO, Baskin CR, Ananieva O, Chang Y, Jacobs BL. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination. Vaccine. 26: 2860-72. PMID 18455281 DOI: 10.1016/j.vaccine.2008.03.044 |
0.792 |
|
| 2008 |
Vijaysri S, Jentarra G, Heck MC, Mercer AA, McInnes CJ, Jacobs BL. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination. Vaccine. 26: 664-76. PMID 18096276 DOI: 10.1016/J.Vaccine.2007.11.045 |
0.798 |
|
| 2008 |
Zhang P, Jacobs BL, Samuel CE. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis. Journal of Virology. 82: 840-8. PMID 17959656 DOI: 10.1128/JVI.01891-07 |
0.397 |
|
| 2007 |
Masci P, Olencki T, Wood L, Rybicki L, Jacobs B, Williams BRG, Faber P, Bukowski R, Tong K, Borden EC. Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon-α1b: A Second Member of the Interferon-α Family Clinical Pharmacology & Therapeutics. 81: 354-361. PMID 17339865 DOI: 10.1038/Sj.Clpt.6100081 |
0.314 |
|
| 2007 |
Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. Journal of Virology. 81: 2554-63. PMID 17182678 DOI: 10.1128/Jvi.01634-06 |
0.401 |
|
| 2006 |
Langland JO, Kash JC, Carter V, Thomas MJ, Katze MG, Jacobs BL. Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins. Journal of Virology. 80: 10083-95. PMID 17005686 DOI: 10.1128/JVI.00607-06 |
0.406 |
|
| 2006 |
Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL. Inhibition of PKR by RNA and DNA viruses. Virus Research. 119: 100-10. PMID 16704884 DOI: 10.1016/J.Virusres.2005.10.014 |
0.344 |
|
| 2005 |
Brandt T, Heck MC, Vijaysri S, Jentarra GM, Cameron JM, Jacobs BL. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response. Virology. 333: 263-70. PMID 15721360 DOI: 10.1016/J.Virol.2005.01.006 |
0.829 |
|
| 2005 |
Jancovich JK, Davidson EW, Parameswaran N, Mao J, Chinchar VG, Collins JP, Jacobs BL, Storfer A. Evidence for emergence of an amphibian iridoviral disease because of human-enhanced spread. Molecular Ecology. 14: 213-24. PMID 15643965 DOI: 10.1111/J.1365-294X.2004.02387.X |
0.349 |
|
| 2005 |
Langland JO, Lancaster V, Jacobs BL. Viral Countermeasures to the Host Interferon Response: Role of the Vaccinia Virus E3L and K3L Genes Antiviral Drug Discovery For Emerging Diseases and Bioterrorism Threats. 353-376. DOI: 10.1002/0471716715.ch15 |
0.401 |
|
| 2004 |
Kibler KV, Miyazato A, Yedavalli VS, Dayton AI, Jacobs BL, Dapolito G, Kim SJ, Jeang KT. Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection. The Journal of Biological Chemistry. 279: 49055-63. PMID 15371436 DOI: 10.1074/jbc.M403394200 |
0.393 |
|
| 2004 |
Langland JO, Jacobs BL. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology. 324: 419-29. PMID 15207627 DOI: 10.1016/j.virol.2004.03.012 |
0.363 |
|
| 2003 |
Jancovich JK, Mao J, Chinchar VG, Wyatt C, Case ST, Kumar S, Valente G, Subramanian S, Davidson EW, Collins JP, Jacobs BL. Genomic sequence of a ranavirus (family Iridoviridae) associated with salamander mortalities in North America. Virology. 316: 90-103. PMID 14599794 DOI: 10.1016/J.Virol.2003.08.001 |
0.316 |
|
| 2003 |
Vijaysri S, Talasela L, Mercer AA, Mcinnes CJ, Jacobs BL, Langland JO. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo. Virology. 314: 305-14. PMID 14517083 DOI: 10.1016/S0042-6822(03)00433-1 |
0.426 |
|
| 2003 |
Kim YG, Muralinath M, Brandt T, Pearcy M, Hauns K, Lowenhaupt K, Jacobs BL, Rich A. A role for Z-DNA binding in vaccinia virus pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 100: 6974-9. PMID 12777633 DOI: 10.1073/Pnas.0431131100 |
0.731 |
|
| 2002 |
Langland JO, Jacobs BL. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology. 299: 133-41. PMID 12167348 DOI: 10.1006/viro.2002.1479 |
0.405 |
|
| 2002 |
Xiang Y, Condit RC, Vijaysri S, Jacobs B, Williams BR, Silverman RH. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. Journal of Virology. 76: 5251-9. PMID 11967338 DOI: 10.1128/Jvi.76.10.5251-5259.2002 |
0.548 |
|
| 2001 |
Jancovich JK, Davids EW, Seiler A, Jacobs BL, Collins JP. Transmission of the Ambystoma tigrinum virus to alternative hosts. Diseases of Aquatic Organisms. 46: 159-63. PMID 11710549 DOI: 10.3354/Dao046159 |
0.428 |
|
| 2001 |
He Y, Tan SL, Tareen SU, Vijaysri S, Langland JO, Jacobs BL, Katze MG. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. Journal of Virology. 75: 5090-8. PMID 11333890 DOI: 10.1128/Jvi.75.11.5090-5098.2001 |
0.324 |
|
| 2001 |
Brandt TA, Jacobs BL. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. Journal of Virology. 75: 850-6. PMID 11134298 DOI: 10.1128/Jvi.75.2.850-856.2001 |
0.773 |
|
| 1998 |
Shors ST, Beattie E, Paoletti E, Tartaglia J, Jacobs BL. Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 18: 721-9. PMID 9781811 DOI: 10.1089/jir.1998.18.721 |
0.332 |
|
| 1998 |
Jacobs BL, Langland JO, Brandt T. Characterization of viral double-stranded RNA-binding proteins. Methods (San Diego, Calif.). 15: 225-32. PMID 9735307 DOI: 10.1006/Meth.1998.0626 |
0.745 |
|
| 1998 |
Jacobs BL, Langland JO. Reovirus sigma 3 protein: dsRNA binding and inhibition of RNA-activated protein kinase. Current Topics in Microbiology and Immunology. 233: 185-96. PMID 9599927 DOI: 10.1007/978-3-642-72092-5_9 |
0.416 |
|
| 1998 |
Rager KJ, Langland JO, Jacobs BL, Proud D, Marsh DG, Imani F. Activation of Antiviral Protein Kinase Leads to Immunoglobulin E Class Switching in Human B Cells Journal of Virology. 72: 1171-1176. DOI: 10.1128/jvi.72.2.1171-1176.1998 |
0.391 |
|
| 1997 |
Shors T, Kibler KV, Perkins KB, Seidler-Wulff R, Banaszak MP, Jacobs BL. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. Virology. 239: 269-76. PMID 9434718 DOI: 10.1006/viro.1997.8881 |
0.39 |
|
| 1997 |
Kibler KV, Shors T, Perkins KB, Zeman CC, Banaszak MP, Biesterfeldt J, Langland JO, Jacobs BL. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. Journal of Virology. 71: 1992-2003. PMID 9032331 DOI: 10.1128/Jvi.71.3.1992-2003.1997 |
0.517 |
|
| 1997 |
Jancovich J, Davidson E, Morado J, Jacobs B, Collins J. Isolation of a lethal virus from the endangered tiger salamander Ambystoma tigrinum stebbinsi Diseases of Aquatic Organisms. 31: 161-167. DOI: 10.3354/Dao031161 |
0.371 |
|
| 1997 |
Kibler KV, Shors T, Perkins KB, Zeman CC, Banaszak MP, Biesterfeldt J, Langland JO, Jacobs BL. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. Journal of Virology. 71: 1992-2003. DOI: 10.1128/jvi.71.3.1992-2003.1997 |
0.33 |
|
| 1996 |
Beattie E, Kauffman EB, Martinez H, Perkus ME, Jacobs BL, Paoletti E, Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes. 12: 89-94. PMID 8879125 DOI: 10.1007/BF00370005 |
0.436 |
|
| 1995 |
Chang HW, Uribe LH, Jacobs BL. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. Journal of Virology. 69: 6605-8. PMID 7666567 DOI: 10.1128/Jvi.69.10.6605-6608.1995 |
0.473 |
|
| 1995 |
Langland JO, Jin S, Jacobs BL, Roth DA. Identification of a plant-encoded analog of PKR, the mammalian double-stranded RNA-dependent protein kinase. Plant Physiology. 108: 1259-67. PMID 7630944 DOI: 10.1104/Pp.108.3.1259 |
0.323 |
|
| 1995 |
Beattie E, Denzler KL, Tartaglia J, Perkus ME, Paoletti E, Jacobs BL. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. Journal of Virology. 69: 499-505. PMID 7527085 DOI: 10.1128/Jvi.69.1.499-505.1995 |
0.518 |
|
| 1995 |
Chang HW, Uribe LH, Jacobs BL. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. Journal of Virology. 69: 6605-6608. DOI: 10.1128/jvi.69.10.6605-6608.1995 |
0.382 |
|
| 1995 |
Beattie E, Denzler KL, Tartaglia J, Perkus ME, Paoletti E, Jacobs BL. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. Journal of Virology. 69: 499-505. DOI: 10.1128/jvi.69.1.499-505.1995 |
0.332 |
|
| 1994 |
Park H, Davies MV, Langland JO, Chang HW, Nam YS, Tartaglia J, Paoletti E, Jacobs BL, Kaufman RJ, Venkatesan S. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proceedings of the National Academy of Sciences of the United States of America. 91: 4713-7. PMID 7515177 DOI: 10.1073/Pnas.91.11.4713 |
0.36 |
|
| 1994 |
Langland JO, Pettiford S, Jiang B, Jacobs BL. Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. Journal of Virology. 68: 3821-9. PMID 7514679 DOI: 10.1128/Jvi.68.6.3821-3829.1994 |
0.317 |
|
| 1991 |
Watson JC, Chang HW, Jacobs BL. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology. 185: 206-16. PMID 1681618 DOI: 10.1016/0042-6822(91)90768-7 |
0.337 |
|
| 1982 |
Jacobs BL, Penhoet EE. Assembly of vesicular stomatitis virus: distribution of the glycoprotein on the surface of infected cells. Journal of Virology. 44: 1047-1055. DOI: 10.1128/jvi.44.3.1047-1055.1982 |
0.714 |
|
| Show low-probability matches. |